Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3 2024-04-09 22:10
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine 2024-04-09 20:00
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting 2024-04-09 19:59
GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting 2024-04-09 19:00
GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting 2024-04-09 19:00
Fiscal Year 2023: Exyte experiences strong growth in Europe and the USA 2024-04-09 17:52
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors 2024-04-09 14:00
Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial 2024-04-09 09:18
Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR 2024-04-09 04:53
MAIWEIJIAN, First Approved Biosimilar of Denosumab (120mg) in China 2024-04-08 22:00
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases" 2024-04-08 20:00
SeekIn Presents New OncoSeek® Data at the AACR Annual Meeting in San Diego 2024-04-08 20:00
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort 2024-04-08 17:19
D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline 2024-04-08 15:00
Laekna Announces Two Poster Presentations on Internally Discovered Drug Candidates at AACR 2024 2024-04-08 08:30
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting 2024-04-08 08:00
FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the First-Line Treatment of Patients with advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations 2024-04-07 19:09
Antengene Presents Four Preclinical Posters at AACR 2024 2024-04-06 08:30
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference 2024-04-05 19:00
HSA approves new asthma indication for GSK's Trelegy Ellipta, the first once-daily single inhaler triple therapy approved for use in the treatment of both asthma and COPD in Singapore 2024-04-05 16:00
1 2 3 4 5 6 374